Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms

Authors

Suzanne E. Wahrle, Washington University School of Medicine in St. Louis
Aarti R. Shah, Washington University School of Medicine in St. Louis
Anne M. Fagan, Washington University School of Medicine in St. LouisFollow
Scott Smemo, Washington University School of Medicine in St. Louis
John SK Kauwe, Washington University School of Medicine in St. LouisFollow
Andrew Grupe, Celera Diagnostics
Anthony Hinrichs, Washington University School of Medicine in St. LouisFollow
Kevin Mayo, Washington University School of Medicine in St. Louis
Hong Jiang, Washington University School of Medicine in St. LouisFollow
Leon J. Thal, University of California - San Diego
Alison M. Goate, Washington University School of Medicine in St. LouisFollow
David M. Holtzman, Washington University School of Medicine in St. LouisFollow

Journal

Molecular Neurodegeneration

Publication Date

2007

Volume

2

Inclusive Pages

7

Document Type

Open Access Publication

Rights and Permissions

Molecular Neurodegeneration 2007, 2:7 http://www.molecularneurodegeneration.com/content/2/1/7 © 2007 Wahrle et al; licensee BioMed Central Ltd.

Recommended Citation

Wahrle, Suzanne E.; Shah, Aarti R.; Fagan, Anne M.; Smemo, Scott; Kauwe, John SK; Grupe, Andrew; Hinrichs, Anthony; Mayo, Kevin; Jiang, Hong; Thal, Leon J.; Goate, Alison M.; and Holtzman, David M., "Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms." Molecular Neurodegeneration. 2, 7. (2007).
https://digitalcommons.wustl.edu/open_access_pubs/186